Order intake continues to outstrip last year's level, Halma says

Alexander Bueso WebFG News | 21 Nov, 2017 08:46 - Updated: 08:50 | | |

  • 1,268.00
  • -0.78%-10.00
  • Max: 1,278.00
  • Min: 1,258.00
  • Volume: 1,196,706
  • MM 200 : n/a
17:18 13/12/17
  • 20,061.40
  • -0.06%-11.62
  • Max: 20,105.15
  • Min: 20,023.39
  • Volume: 0
  • MM 200 : n/a
17:19 13/12/17
  • 6,528.33
  • -0.33%-21.53
  • Max: 6,594.95
  • Min: 6,493.95
  • Volume: 0
  • MM 200 : n/a
17:19 13/12/17
  • 4,165.37
  • -0.05%-2.21
  • Max: 4,172.97
  • Min: 4,164.26
  • Volume: 0
  • MM 200 : n/a
17:19 13/12/17
  • 4,111.96
  • -0.05%-2.13
  • Max: 4,119.21
  • Min: 4,111.04
  • Volume: 0
  • MM 200 : n/a
17:30 13/12/17
  • 0.00
  • 0.00%0.00
  • Max: n/a
  • Min: n/a
  • Volume: n/a
  • MM 200 : n/a
17:17 25/09/06

Instrumentation specialist Halma announced a further increase in its dividend payout at the half-year stage as solid top-line growth continued to drop through to the bottom line at a steady pace with order intake since period-end continuing to outpace last year's showing.

Over the six months ending on 30 September, sales at the safety and risk specialist jumped 15% to £506.3m, driving a 18% rise in statutory profits to £76.8m.

However, in adjusted terms profits before tax were up by a tamer 13% to £94.5m and by 8% when the benefits of FX tailwinds are stripped out.

"Since the period end, order intake has continued to be ahead of revenue and order intake last year. Halma remains on track to make progress in the second half of the year in line with the Board's expectations," said chief Andrew Williams.

According to the company, its return on total invested capital rose by 13.4% during the period, amid "good" organic revenue growth at constant currencies across all four of its operating units: Process safety, Infrastructure safety, medical and Environmental&Analysis.

Sales were also higher across all regions, especially in Asia Pacific, the company said in a statement.

However, outlays on research and development were ratcheted up by 19% to £27.3m or 5.4% of group sales, versus 5.2% in the comparable year-ago period, with management highlighting increased rates of investment in the Medical and Environmental&Analysis units.

Two acquisitions were completed during the first half and a further two since period-end.

At the end of September, net debt had been cut from £237.3m one year ago to £1810m.

The half-year payout was bumped up 7% to 5.71p.

Commenting on the company's results, ShoreCap's Ben McSkelly pointed out the 6% organic decline in the Medical segment's PBT margin - although Halma said the unit was "on track to improve profitability in the second half" - and 20 basis point erosion in the firm's return on sales to 18.7%, alongside a "slight" tick lower in its gross margins.

Nonetheless, McSkelly added: "Halma is a high quality business and with the strong performance seen here, we believe Halma merits a move to BUY at last night’s closing price (albeit we expect the shares to move this morning)."

More news

13 Dec US close: Stocks end on mixed note, despite Fed and tax cuts

Stocks finished on a mixed note after two rate-setters dissented from the Federal Reserve's widely-expected decision to hike rates.

13 Dec Sector movers: Financials pace gains ahead of central bank policy decisions

Cyclicals paced gains on Wednesday, alongside a bounce in food retailers with financials figuring prominently ahead of interest rate decisions from the Federal Reserve on Wednesday evening, as well as the Bank of England and European Central Bank the next day.

13 Dec Director dealings: Ashtead's top brass sell at 52-week high

A large swathe of US-focused equipment rental company Ashtead's top brass offloaded a large part of their holdings of stock in the company even as the price hit a 52-week high.

13 Dec Europe close: Stocks hit by strong euro, Italian political uncertainty

Stocks sagged as a weaker-than-expected reading on US inflation sent the single currency higher ahead of the US central bank's policy announcement later on Wednesday, with Italian stocks also battered by reports which, analysts said, held out the prospect for political instability in the Eurozone's third-largest economy in 2018.

13 Dec Disney close to sealing $60bn deal for Fox and Sky stake - reports

Walt Disney is reportedly set to secure a $60bn deal to buy 21st Century Fox’s entertainment assets, including its 39% stake in UK broadcaster Sky.

13 Dec FOMC hikes rates, but Evans and Kashkari dissent

The US central bank went ahead with its third rate hike of 2018, as expected, but two rate-setters dissented, voting instead for no change.

13 Dec London close: Stocks flat as traders wait on US Fed

London stocks were little changed on Wednesday as investors digested some mixed UK jobs data and looked ahead to the latest policy announcement from the Federal Reserve.

13 Dec US open: Stocks rise ahead of Fed rate decision

Stocks are trading higher ahead of the US central bank's policy announcement later in the day, bolstered by a weaker than expected reading on consumer prices.

13 Dec Thursday preview: BoE, ECB, European Council, Bunzl, Ocado, Sports Direct

Thursday is a big day for the Brexit process as the European Council begins its two-day meeting in Brussels, while the Bank of England's and European Central Bank's rate setters are also convening and results are expected from the likes of Bunzl, Cussons, Ocado and Sports Direct.

13 Dec Gasoline stockpiles build alongside increased domestic output

US crude oil inventories shrank more quickly than expected last week, albeit a large increase in domestic output and an offsetting large build in gasoline stockpiles.